Search results
CRISPR Therapeutics Stock (NASDAQ:CRSP): Will It Take Off Anytime Soon?
TipRanks via Yahoo Finance· 7 hours agoDespite my optimism about the long-term prospects of curative gene therapy and CRISPR Therapeutics...
Roche partners with Ascidian Therapeutics to develop gene therapies
Reuters· 1 day ago, opens new tab will team up with privately held biotech Ascidian Therapeutics to develop gene...
GC Cell Signs an MOU with PT Bifarma Adiluhung, an affiliate of KALBE group
Benzinga· 1 hour agoGC Cell and PT Bifarma Adiluhung announced a strategic partnership to facilitate the entry of 'Immuncell-LC', the only approved autologous T-cell therapy for HCC into the Indonesian market.YONGIN, South Korea,
Rare gene mutation helps people resist Alzheimer’s disease
Washington Post· 5 hours agoScientists studied her DNA and scanned her remarkable brain, ultimately tracing her protection to a...
FDA official: The risk of secondary cancer from CAR-T therapy is less than feared
Medical Xpress· 2 days agoThe risk of secondary cancer after CAR-T therapy, pioneered at Penn, is less than regulators feared...
Taysha Gene Therapies’ (TSHA) “Buy” Rating Reaffirmed at Needham & Company LLC
ETF DAILY NEWS· 3 days agoTaysha Gene Therapies (NASDAQ:TSHA – Get Free Report)‘s stock had its “buy” rating restated by Needham & Company LLC in a research report issued to clients and investors on ...
Lung cancer: Why non-smokers don't respond to treatments
Medical News Today· 7 days agoResearchers report that people who have never smoked are less likely to respond to standard ...
Lung-targeted CRISPR therapy offers hope for cystic fibrosis
New Scientist· 7 days agoA CRISPR gene-editing therapy has the potential to offer an effective, long-lasting treatment for...
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
Live Science via Yahoo News· 6 days agoA closer look at the woman's tumor revealed that the CAR-positive cancer cells had unusual changes...
Treatment of Blood Cancers
Digital Journal· 2 days ago(NYSE American: ATNM). Actinium is a leader in the development of Antibody Radiation Conjugates (ARCs...
